Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.
Kyverna Therapeutics
7 followers
Artiva Biotherapeutics
2 followers
UNC Charlotte
13 followers
Enliven Therapeutics
1 follower
Vera Therapeutics
6 followers
School District of Philadelphia
5 followers
Alpha
5 followers
DECA
4 followers
FieldGuide
4 followers
Mineralys Therapeutics
3 followers
iGEM
1 follower
Mirum Pharmaceuticals
9 followers